Investor profile
Epidarex Capital has backed 8 European tech companies across 8 funding rounds between 2015 and 2024, joining rounds totalling €101M. Most active in Healthtech. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Enterprise Therapeutics | UK | 1 | €30M |
| Topas Therapeutics | Germany | 1 | €18M |
| Transine Therapeutics | UK | 1 | €16M |
| Leucid Bio | UK | 1 | €14M |
| Caldan Therapeutics | UK |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Enterprise Therapeutics | Series B | €30M | 2024-01 |
| Topas Therapeutics | Series B | €18M | 2021-07 |
| Transine Therapeutics | Seed | €16M | 2022-06 |
| Leucid Bio |
| 1 |
| €6.3M |
| Mironid | UK | 1 | €6.0M |
| Theolytics | UK | 1 | €5.5M |
| Macomics | UK | 1 | €5.0M |
| Series A |
| €14M |
| 2021-10 |
| Caldan Therapeutics | Series A | €6.3M | 2015-11 |
| Mironid | Series A | €6.0M | 2016-06 |
| Theolytics | Series A | €5.5M | 2021-01 |
| Macomics | Other | €5.0M | 2021-07 |
